These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23904396)

  • 21. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. No good evidence to promote a general use of sevelamer.
    Nguyen QV; Descombes E
    Kidney Int; 2008 Jan; 73(2):238-9, author reply 239. PubMed ID: 18165813
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.
    Suki WN; Zabaneh R; Cangiano JL; Reed J; Fischer D; Garrett L; Ling BN; Chasan-Taber S; Dillon MA; Blair AT; Burke SK
    Kidney Int; 2007 Nov; 72(9):1130-7. PubMed ID: 17728707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epicardial adipose tissue volume and cardiovascular disease in hemodialysis patients.
    Turan MN; Gungor O; Asci G; Kircelli F; Acar T; Yaprak M; Ceylan N; Demirci MS; Bayraktaroglu S; Toz H; Ozkahya M; Ok E
    Atherosclerosis; 2013 Jan; 226(1):129-33. PubMed ID: 23159099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RenaGel efficacy in severe secondary hyperparathyroidism.
    Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M
    Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epicardial adipose tissue and coronary artery calcification in diabetic and nondiabetic end-stage renal disease patients.
    Tonbul HZ; Turkmen K; Kayıkcıoglu H; Ozbek O; Kayrak M; Biyik Z
    Ren Fail; 2011; 33(8):770-5. PubMed ID: 21770856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
    Raggi P; James G; Burke SK; Bommer J; Chasan-Taber S; Holzer H; Braun J; Chertow GM
    J Bone Miner Res; 2005 May; 20(5):764-72. PubMed ID: 15824849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epicardial adipose tissue radiodensity is associated with all-cause mortality in patients undergoing hemodialysis.
    Kwon SS; Choi K; Da Nam B; Lee H; Cho NJ; Park BW; Kim H; Noh H; Jeon JS; Han DC; Oh S; Kwon SH
    Sci Rep; 2021 Nov; 11(1):23090. PubMed ID: 34845284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to interpret epicardial adipose tissue as a cause of coronary artery disease: a meta-analysis.
    Xu Y; Cheng X; Hong K; Huang C; Wan L
    Coron Artery Dis; 2012 Jun; 23(4):227-33. PubMed ID: 22361934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
    Mason MA; Shepler BM
    Pharmacotherapy; 2010 Jul; 30(7):741-8. PubMed ID: 20575637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women.
    de Vos AM; Prokop M; Roos CJ; Meijs MF; van der Schouw YT; Rutten A; Gorter PM; Cramer MJ; Doevendans PA; Rensing BJ; Bartelink ML; Velthuis BK; Mosterd A; Bots ML
    Eur Heart J; 2008 Mar; 29(6):777-83. PubMed ID: 18156138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epicardial fat accumulation, cardiometabolic profile and cardiovascular events in patients with stages 3-5 chronic kidney disease.
    Cordeiro AC; Amparo FC; Oliveira MA; Amodeo C; Smanio P; Pinto IM; Lindholm B; Stenvinkel P; Carrero JJ
    J Intern Med; 2015 Jul; 278(1):77-87. PubMed ID: 25556720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis.
    Shimabukuro M; Hirata Y; Tabata M; Dagvasumberel M; Sato H; Kurobe H; Fukuda D; Soeki T; Kitagawa T; Takanashi S; Sata M
    Arterioscler Thromb Vasc Biol; 2013 May; 33(5):1077-84. PubMed ID: 23471228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease.
    Rallidis LS; Varounis C; Sourides V; Charalampopoulos A; Kotakos C; Liakos G; Dagres N; Apostolou T; Anastasiou-Nana M
    Curr Med Res Opin; 2011 Jul; 27(7):1407-13. PubMed ID: 21568834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of sevelamer on dyslipidemia and chronic inflammation in maintenance hemodialysis patients.
    Yamada K; Fujimoto S; Tokura T; Fukudome K; Ochiai H; Komatsu H; Sato Y; Hara S; Eto T
    Ren Fail; 2005; 27(4):361-5. PubMed ID: 16060120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis.
    Matsuoka M; Iseki K; Tamashiro M; Fujimoto N; Higa N; Touma T; Takishita S
    Clin Exp Nephrol; 2004 Mar; 8(1):54-8. PubMed ID: 15067517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimum second screening point for detection of coronary artery disease in hemodialysis patients without advanced coronary artery disease.
    Joki N; Tanaka Y; Ishikawa H; Takahashi Y; Iwakura Y; Masuda H; Inishi Y; Hase H
    Am J Nephrol; 2009; 29(5):420-5. PubMed ID: 18997458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis comparing sevelamer and calcium-based phosphate binders on cardiovascular calcification in hemodialysis patients.
    Zhang Q; Li M; Lu Y; Li H; Gu Y; Hao C; Chen J
    Nephron Clin Pract; 2010; 115(4):c259-67. PubMed ID: 20424476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonthyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis?
    Meuwese CL; Carrero JJ; Cabezas-Rodríguez I; Heimburger O; Barany P; Lindholm B; Qureshi AR; Ripsweden J; Dekker FW; Stenvinkel P
    J Intern Med; 2013 Dec; 274(6):584-93. PubMed ID: 23815158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.